FEMGYL 50 MG-5 MG/1 ML SOLUCIÓN OLEOSA INYECTABLE I.M. Panama - engelska - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

femgyl 50 mg-5 mg/1 ml solución oleosa inyectable i.m.

gutis, ltda. - noretisterona enantato - noretisterona enantato....50mg / estradiol valerato....5mg

BenQ miacare CONFiDENCE Color Contact Lens with EautraSil Plus Singapore - engelska - HSA (Health Sciences Authority)

benq miacare confidence color contact lens with eautrasil plus

qualtech consulting corporation pte. ltd. - ophthalmology - miacare confidence color contact lens with eautrasil plus is indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic or aphakic persons with non-diseased eyes.

MIRTAZAPINE tablet film coated USA - engelska - NLM (National Library of Medicine)

mirtazapine tablet film coated

unit dose services - mirtazapine (unii: a051q2099q) (mirtazapine - unii:a051q2099q) - mirtazapine 15 mg

MIRTAZAPINE tablet, film coated USA - engelska - NLM (National Library of Medicine)

mirtazapine tablet, film coated

tya pharmaceuticals - mirtazapine (unii: a051q2099q) (mirtazapine - unii:a051q2099q) - mirtazapine tablets, usp are indicated for the treatment of major depressive disorder.   the efficacy of mirtazapine tablets, usp in the treatment of major depressive disorder was established in six week controlled trials of outpatients whose diagnoses corresponded most closely to the diagnostic and statistical manual of mental disorders – 3rd edition (dsm-iii) category of major depressive disorder (see ).  clinical pharmacology a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation.  the

BICA VERA 2.3 % GLUCOSE 1.75 MMOLL CALCIUM Israel - engelska - Ministry of Health

bica vera 2.3 % glucose 1.75 mmoll calcium

fresenius medical care israel p.b., ltd. - calcium chloride dihydrate; calcium chloride dihydrate; glucose monohydrate; glucose monohydrate; magnesium chloride hexahydrate; magnesium chloride hexahydrate; sodium chloride; sodium chloride; sodium hydrogen carbonate; sodium hydrogen carbonate - solution for peritoneal dialysis - sodium chloride 11.57 g/l; calcium chloride dihydrate 0.5145 g/l; magnesium chloride hexahydrate 0.2033 g/l; glucose monohydrate 25.0 g/l; magnesium chloride hexahydrate 0.1017 g/l; calcium chloride dihydrate 0.2573 g/l; sodium hydrogen carbonate 2.940 g/l; sodium chloride 5.786 g/l; sodium hydrogen carbonate 5.880 g/l; glucose monohydrate 50.00 g/l - combinations of electrolytes - combinations of electrolytes - end-stage (decompensated ) chronic renal failure of any origin treated with peritoneal dialysis.17/10/2017 בקשה לשינוי משטר מינון שינוי משטר מינון בהתאם למאושר באירופה

BICA VERA 4.25 % GLUCOSE 1.75 MMOLL CALCIUM Israel - engelska - Ministry of Health

bica vera 4.25 % glucose 1.75 mmoll calcium

fresenius medical care israel p.b., ltd. - calcium chloride dihydrate; calcium chloride dihydrate; glucose as monohydrate; glucose monohydrate; magnesium chloride hexahydrate; magnesium chloride hexahydrate; sodium chloride; sodium chloride; sodium hydrogen carbonate; sodium hydrogen carbonate - solution for peritoneal dialysis - sodium chloride 11.57 g/l; calcium chloride dihydrate 0.5145 g/l; magnesium chloride hexahydrate 0.2033 g/l; glucose as monohydrate 93.50 g/l; glucose monohydrate 46.75 g/l; magnesium chloride hexahydrate 0.1017 g/l; calcium chloride dihydrate 0.2573 g/l; sodium hydrogen carbonate 2.940 g/l; sodium chloride 5.786 g/l; sodium hydrogen carbonate 5.880 g/l - combinations of electrolytes - combinations of electrolytes - end-stage (decompensated ) chronic renal failure of any origin treated with peritoneal dialysis.17/10/2017 בקשה לשינוי משטר מינון שינוי משטר מינון בהתאם למאושר באירופה

SERTRALINE HYDROCHLORIDE tablet USA - engelska - NLM (National Library of Medicine)

sertraline hydrochloride tablet

tya pharmaceuticals - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline 50 mg - – sertraline hydrochloride is indicated for the treatment of major depressive disorder in adults. major depressive disorder the efficacy of sertraline hydrochloride in the treatment of a major depressive episode was established in six to eight week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see under ). clinical trialsclinical pharmacology a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the

SERTRALINE tablet, film coated USA - engelska - NLM (National Library of Medicine)

sertraline tablet, film coated

tya pharmaceuticals - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline 25 mg - sertraline hydrochloride tablets usp are indicated for the treatment of major depressive disorder in adults. the efficacy of sertraline hydrochloride tablets usp in the treatment of a major depressive episode was established in six to eight week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see under ). clinical trials clinical pharmacology a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the antidepressant action